Latest News - United States - California - Monrovia

Michael Karin, Professor of Pharmacology Tumor Growth Invasion & Metastasis at UCSD to Give Keynote Speech at GTCbio’s 7th Cytokines & Inflammation Conference on January 29-30, 2009 in San Diego, CA

GTCbio just announced its 7th Annual Conference on Cytokines & Inflammation scheduled for January 29-30, 2009 in Sunny San Diego, California.

Dr. Samir Hanash, Program Head at the Fred Hutchinson Cancer Research Center in Seattle, WA will give the keynote address on the discovery and development of biomarkers at the 2nd annual Oncology Biomarkers Conference on Jan. 19-20 in Miami, Florida

GTCbio just announced its 2nd Annual Oncology Biomarkers Conference taking place on January 19-20, 2009 in Miami, Florida.

Michael Shih of Eisai Inc. and Deepa Talpade from Schering Plough will give the joint featured address entitled “CNS Deal Outlook: What We Can Learn From Recent Trends” at CNS Diseases Partnering forum.

GTCbio announced its Inaugural CNS Partnering & Deal-Making Summit being held on December 1-2, 2008 in Boston, MA.

Robert Davie, VP at Covance presenting “The Service Provider Perspective: How are CROs Preparing for the Future of Clinical Outsourcing?” at GTCbio’s Global Clinical Trial Operations Conference

Peter Mayne from OSI Pharmaceuticals presenting on being an EU Qualified Person (QP) as a small offshoot of a virtual company at GTCbio’s Global Clinical Trial Operations conference

Michele Pontinen from Capgemini presenting “Forget About the Boulders – I’m Interested in Mining for the Diamonds!” Data Mining Made Possible by Clinical IT at GTCbio’s Global Clinical Trial Operations Conference

Mark Lanfear, Regional Manager of Kforce-Roche Strategic Alliance at Roche to present on outsourcing clinical trials in emerging regions at GTCbio’s Global Clinical Trial Operations Conference

Laurence Flint, Associate Director of Clinical Research at Schering-Plough Research Institute, to present on practical approaches for pediatric trials at GTCbio’s Global Clinical Trial Operations Conference

Larry A Blankstein from Genzyme giving a presentation entitled “An Interactive Lessons Learned Process to Optimize Sponsor and Provider Performance on Global Trials” at GTCbio’s Global Clinical Trial Operations conference

Kathleen Moran, VP of Clinical Operations at Acurian giving a presentation entitled “Triaging Recruitment Costs: Media, Outreach and Internet” at GTCbio’s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA

Kathleen Drennan from Iris Global Clinical Trial Solutions giving a presentation entitled “Clinical Trials In Kids; A Special Population Requiring A Unique Approach” at GTCbio’s Global Clinical Trial Operations Conference

Dr. Helen Niu, Director of Global Development Operations at Amgen presenting on development strategies for bio-pharmaceuticals in emerging Asian countries at GTCbio’s Global Clinical Trial Operations Conference on Sept 25-26 in San Diego

Gavin Choy, VP of Clinical Research Operations at SuperGen, Inc. giving a presentation entitled ADME in Phase 1 Clinical Trials at GTCbio’s Global Clinical Trial Operations Conference on September 25-26, 2008 in San Diego

Franco Pasquale, Sr Manager of Manufacturing Collaborations at Genentech to present on devising an international clinical trial distribution strategy using Genentech’s approach at GTCbio’s Global Clinical Trial Operations Conference in San Diego

Didier Basseras from Sanofi Aventis will give a presentation entitled “Clinical Packaging and Labelling: Is There Room to Innovate?” at GTCbio’s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA.

Cosimo Spera from Decision View Co. will give a presentation entitled “Marrying Complex Mathematical Models with Highly Usable Software Solutions to Improve Trial Enrollment Performance” at GTCbio’s Global Clinical Trial Operations Conference

Charlene Dark, Dir. of Life Sciences at Clarkston Consulting will be present on expediting accuracy through electronic data capture at GTCbio’s Global Clinical Trial Operations Conference on Sept. 25-26 in San Diego.

Brahm Goldstein Novo Nordisk speaking regarding a rational approach towards pediatric drug development in the pharmaceutical industry at GTCbio’s Global Clinical Trial Operations Conference

Amrit Ray, VP of BMS to give the keynote presentation entitled Next Generation of Pharmacovigilance - Clinical Trials and Drug Development in the New Era of Drug Safety at GTCbio’s Global Clinical Trial Operations Conf on Sept 25-26 in San Diego

Ondax, Inc, a leader in the design and manufacture of volume holographic gratings (VHGs) and wavelength stabilized, single mode semiconductor lasers, announces that it was granted a new patent from the United States Patent and Trademark Office.

Dr. Clay Scott, Associate Director of the Lead Generation Department at AstraZeneca will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA.

Dr. Taosheng Chen, Director of HTS, St. Jude Children's Research Hospital will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA.

Dr. Xi Chen, Assistant Professor in the Department of Chemistry at the University of California, Davis will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA

Dr. John W. Cuozzo, Director of ELT Lead Discovery at GlaxoSmithKline will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA.

Hakim Djaballah, Director of HTS at Memorial Sloan Kettering Cancer Center to Present at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA

Dr. Berta Strulovici, Vice President of Basic Research MRL, and Automated Biotechnology Head at Merck & Co. will give Keynote Presentation at GTCbio’s 4th Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA.

Jeremy Caldwell, Executive Director of Molecular and Cell Biology at the Genomics Institute of the Novartis Research Foundation to give the Featured Presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008

Dr. Robert Hertzberg, of GlaxoSmithKline will give the Keynote Presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA. Dr. Hertzberg will present on “High Throughput Screening"

GTCbio just announced its holding the annual Modern Drug Discovery and Development Summit taking place on October 15-17, 2008 in San Diego, CA.

Ondax, a leading manufacturer of Volume Holographic Gratings and Single-Mode Wavelength Stabilized Laser Diodes, has introduced a new product line of ASE Suppression Filters.

Ondax, a leading manufacturer of Volume Holographic Gratings and Single-Mode Wavelength Stabilized Laser Diodes has pushed their photosensitive glass to a new level of performance.

Ondax, a leading manufacturer of Volume Holographic Gratings, expands its product portfolio with the introduction of Multi-Mode Fiber Pigtailed, Single-Mode Wavelength Stabilized Laser Diodes.

Ondax Offers a Low Profile, Wavelength Stabilized Laser at 405nm. The stabilized lasers have a single-mode, narrow linewidth, very low temperature dependence and a coherence length of 1 meter.

Presenters from GSK, Pfizer, Abbott, Schering-Plough, Bristol-Myers Squibb, GE, Siemens, NIH and more to speak at GTCbio’s 3rd Imaging in Drug Development conference on March 17-18, 2008 in San Diego.

Robert Copeland, VP of Biology, Oncology Center of Excellence in Drug Discovery at GlaxoSmithKline to give keynote presentation at 5th Cancer Drugs R&D conference on February 21-22, 2008 in Phoenix

Joost J. Oppenheim, Chief of the Laboratory of Molecular Immunoregulation at NCI, NIH, will be the honored keynote speaker at the 6th Cytokines and Inflammation conference to be held January 28-29, 2008 in Orlando, FL

Thomas Waldmann, Chief of Metabolism & Head of Cytokine Immunology/ Immunotherapy at NCI to give keynote presentaion at 2nd Immunodiagnostics & Immunomonitoring conference December 6-7, 2007

Robert Copeland, VP of Biology, Oncology Center of Excellence in Drug Discovery at GlaxoSmithKline to give keynote presentation at 5th Cancer Drugs R&D conference on February 21-22, 2008 in Phoenix.

Kenna Anderes of Pfizer Global R&D, Michael Shi of Novartis and Joseph Paul Eder of AstraZeneca to give featured presentations at Oncology Biomarkers: From Discovery to Validation conference on January 14-15, 2008.

David Kaslow, at Merck to give Keynote presentation at GTCbio’s Biological Therapeutics conference – 1 of 6 tracks at 3rd Modern Drug Discovery & Development Summit on Nov 28-30, 2007 in San Fran

Stephen Burley, at SGX Pharmaceuticals to give Keynote talk at Drug Design & Lead Discovery conference– 1 of 6 tracks at 3rd Modern Drug Discovery & Development Summit on Nov 28-30, 2007 in San Fran

The 3rd World Summit on Metabolic Diseases explores the latest findings and treatments for Metabolic Diseases

GTCbio announces it’s the 5th anniversary of its vaccine conference held annually in Washington D.C.

COO of Chorus, Eli Lilly & Co. announced as Plenary Keynote Speaker for the 3rd Modern Drug Discovery & Development Summit (M3D).

GTCbio announces its 3rd Modern Drug Discovery and Development Summit (M3D) on Nov. 28-30, 2007 in San Francisco – featuring 4 keynote speeches from top level execs at Pfizer, Eli Lilly, Wyeth as well as Nobel Laureate Ferid Murad at UT Houston.

Nobel Laureate Ferid Murad announced as Plenary Keynote Speaker for the 3rd Modern Drug Discovery & Development Summit (M3D).

SVP and Site Head of Pfizer La Jolla announced as Plenary Keynote Speaker for the 3rd Modern Drug Discovery & Development Summit (M3D).